| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $221.8M | -15.1% | -14.4% |
| Cost of Revenue | $94.0M | -5.5% | -0.9% |
| Gross Profit | $127.8M | -21.0% | -22.1% |
| R&D Expense | $5.4M | +17.4% | -32.5% |
| SG&A Expense | $76.2M | -1.8% | -4.3% |
| Operating Income | $35.0M | -58.0% | -44.4% |
| Pre-tax Income | $9.5M | -83.9% | -73.5% |
| Income Tax | $13.6M | -8.1% | +10.6% |
| Net Income | -$4.1M | -109.3% | -117.4% |
| EPS (Basic) | -$0.07 | -109.3% | -117.5% |
| EPS (Diluted) | -$0.07 | -109.5% | -117.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $184.9M | -8.1% | -11.7% |
| Accounts Receivable | $147.1M | -7.6% | -20.7% |
| Inventory | $192.6M | +5.9% | +13.8% |
| Current Assets | $608.1M | -2.0% | -5.5% |
| Total Assets | $1.03B | -3.2% | -8.1% |
| Current Liabilities | $247.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $48.3M | +180.8% | — |
| Capital Expenditures | $1.1M | +83.3% | — |
| Investing Cash Flow | $9.0M | -5.3% | — |
| Financing Cash Flow | -$93.1M | -80.4% | — |
| Free Cash Flow | $47.2M | +184.3% | — |
| -4.6% |
| Long-term Debt | $1.32B | -2.7% | -12.7% |
| Stockholders' Equity | -$626.1M | -2.1% | +15.0% |